Related Experiment Video

Updated: Jul 3, 2026

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections

V S Georgiev1

  • 1National Institute of Allergy and Infectious Diseases, NIH, Solar Building, Room 4C-04, Bethesda, MD 20892, USA.

International Journal of Antimicrobial Agents
|January 1, 1994
PubMed

Insights

Mycobacterium avium complex (MAC) infections are a major threat for AIDS patients, with limited effective treatments. Research is exploring novel drugs and immune strategies to combat these opportunistic infections.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pharmacology

Background:

  • Opportunistic infections, particularly Mycobacterium avium complex (MAC), present significant morbidity and mortality challenges in Acquired Immunodeficiency Syndrome (AIDS) patients.
  • MAC infections are the most common bacterial isolates in individuals with AIDS, highlighting a critical unmet medical need.
  • Current therapeutic options for MAC infections in AIDS patients remain limited, with no universally effective drugs or drug combinations available.

Purpose of the Study:

  • To review the current landscape of Mycobacterium avium complex (MAC) infections in AIDS patients.
  • To discuss the limitations of conventional and existing therapies for MAC infections.
  • To explore emerging therapeutic strategies and research directions for treating MAC infections in the context of AIDS.

Main Methods:

  • Review of existing literature on MAC infections in AIDS.
  • Analysis of conventional and reported drug treatments for MAC.
  • Examination of ongoing research into novel antimicrobial agents and host-directed therapies.

Main Results:

  • Conventional multi-drug regimens and prophylactic treatments like rifabutin are widely used but often insufficient.
  • Emerging research focuses on new quinolones, macrolides, folate antagonists, and antimycobacterial antibiotics.
  • Novel strategies targeting mycobacterial cell wall biosynthesis and the role of cytokines in immune defense are under investigation.

Conclusions:

  • Effective treatment for MAC infections in AIDS patients remains a significant challenge.
  • Active research into novel antimicrobial drugs and immunomodulatory approaches offers promise for future therapies.
  • A combination of pharmacological and immunological strategies may be necessary to effectively manage MAC infections in this vulnerable population.

More Related Videos

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally05:40

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally

Published on: April 25, 2025

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...